Skip to content

Clinical trials

Withdrawn Central Nervous System Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Status: Withdrawn Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20102
20151
20191
20212
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
NYU Langone Health2
Pediatric Brain Tumor Consortium2
Helsinn Healthcare SA1
Lisata Therapeutics, Inc.1
Mayo Clinic1
National Cancer Institute (NCI)1
Roger Packer1
SynerGene Therapeutics, Inc.1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms14
Astrocytoma2
Choroid Plexus Neoplasms2
Glioblastoma2
Gliosarcoma2
Hodgkin Disease2
Lymphoma2
Lymphoma, Non-Hodgkin2
Neuroblastoma2
Rhabdoid Tumor2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.